NEU 2.50% $15.59 neuren pharmaceuticals limited

Share Price, page-10812

  1. 1,725 Posts.
    lightbulb Created with Sketch. 200
    I think it will be interesting to see what happens if we do get a stronger than expected result for Q2 for Daybue. ACAD is already -50% YTD and according to this 7.6% of their issued shares are short sold (as of last month). At this point expectations are very low, and the only thing that should continue this pressure would be pulling guidance. I thought that was the case a few months ago, and I was wrong. At the very least NEU has found some support over the last few months and has continued to plunge further down. ACAD has only recently seemed to have found that support.

    It will be an interesting few months, and I still am hopeful for an incredible year for calendar year 2024 despite how it has started (share price wise).
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$15.59
Change
0.380(2.50%)
Mkt cap ! $1.992B
Open High Low Value Volume
$15.51 $15.82 $15.46 $11.26M 722.0K

Buyers (Bids)

No. Vol. Price($)
1 696 $15.59
 

Sellers (Offers)

Price($) Vol. No.
$15.67 6942 8
View Market Depth
Last trade - 16.10pm 30/08/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.